Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-10-04, 09:33:57 | version 1.38.0
| meetings Nobel Biocare Global Symposium 58 CAD/CAM 3 2016 “The journey of innovating the clinical workflow has just begun” An interview with Hans Geiselhöringer, President of Nobel Biocare From 23 to 26 June, Nobel Biocare held its global symposium in the world metropolis of New York in the US. The company staged a truly exceptional event with a high-class educational programme at the Waldorf Astoria in Manhattan. As the official media partner of the event, Dental Tribune Interna- tional had the opportunity to meet with Hans Geiselhöringer,PresidentofNobelBiocareandDen- talImaging,atthesymposiumforashortinterview. Dental Tribune International: Has the global symposium met your expectations? Hans Geiselhöringer: We are extremely happy with the symposium because it has exceeded our expec- tationsineverysense,regardingtherecordnumber of participants, the motivation of our team and customers to engage in discussions, as well as the quality of the speakers and their presentations. We have always had high standards at our meet- ings, but I must say that I was really thrilled by the way innovation was presented not only by our company but also by the clinicians and experts themselves. In addition, I found the NEXT GEN forum in particu- lar incredible, as it gave us confirmation that we are on the right track to doing more for the younger generation of implantologists. I was positively sur- prised to see how enthusiastic and open our young clinicians are to working hard with us to move this project forward. Overall, we have seen at this symposium that the future is bright, and I strongly disagree with some critical voices that suggest that there will no longer be real innovations in implantology. In my opinion, the journey of innovating the clinical workflow has just begun. With regard to training of the next generation of dentists, what role can or should Nobel Biocare play in implant education? Educationiskey.Webelievethatitisveryimportant that clinicians start the thought process for the clinical workflow early. We have some programmes inplacealreadyandwillpromotetheseprogrammes to help and support universities in the education of young dentists in implantology. For example, we support academic institutions and dental students through the provision of NobelClinician Software licences for implant planning and patient commu- nication. Only recently, voters in the UK decided that the country should leave the European Union. How could the Brexit affect the dental industry and are there any immediate concerns for Nobel Biocare? This is a question that is really difficult to answer, as the short- and long-term consequences of the Hans Geiselhöringer spoke about Nobel Biocare’s strategic development at the company’s global sympsosium in New York. (Photograph: Georg Isbaner, OEMUS MEDIA) 32016